Tanja Obradovic, Oncology Medical Strategy Adviser, Clinical Drug Development Expert, shared a post on LinkedIn:
“Very insightful report on the current state of oncology landscape in the US is just published by HealthCentral.
An online survey of 293 physicians, physician assistants, nurses/advanced practice nurses, and pharmacists was done to gain insight into practice patterns and opinions during the past 12 months (October 2024–September 2025). Very informative data across questions of true impact of newly approved drugs, cancer drug performance in the clinic in terms of safety and efficacy vs one reported in clinical trials, impact and utilization of newly approved therapies, clinical development strategies and FDA stand as well as current critical oncology trends.
Indeed deeply informative report across question areas from wide spectrum of oncology practitioners-independent (36%), hospital (31%), academic medical center (29%), government (2%), and other (2%).”
Have a look at the Oncology Drug Report 2026.
More posts from Tanja Obradovic on OncoDaily.